Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample Sinikka L. Kvamme, Michael M. Pedersen, Kristine Rømer Thomsen & Birgitte Thylstrup Background The use of cannabis as medicine (CaM) both prescribed and non-prescribed has increased markedly in the last decade, mirrored in a global shift in cannabis policy […]
Read MoreProportion of Prescribed Conditions & Latest Patient Approval Numbers To date, the TGA has approved SAS applications including, but not limited to, the following indications: chemotherapy-induced nausea and vomiting refractory paediatric epilepsy palliative care indications cancer pain neuropathic pain spasticity from neurological conditions anorexia and wasting associated with chronic illness (such as cancer) A break […]
Read MoreCannabis Nausea Study Abstract Goals: We measure for the first time how a wide range of cannabis products affect nausea intensity in actual time. Background: Even though the Cannabis plant has been used to treat nausea for millennia, few studies have measured real-time effects of common and commercially available cannabis-based products. Study: Using the Releaf App, 886 […]
Read More